Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1976
Kiniksa Pharmaceuticals
KNSA
$7.43B
| $64.7M | ﹤0.01% |
1,011,143
+13,357
| +1% | +$693K |
2018 Q2
32 quarters
|
|
1977
Integra LifeSciences
IART
$952M
| $64.5M | ﹤0.01% |
3,593,079
+8,924
| +0.2% | +$125K |
2013 Q2
52 quarters
|
|
1978
Vontier
VNT
$4.73B
| $64.5M | ﹤0.01% |
2,224,494
+424,626
| +24% | +$13.6M |
2020 Q4
22 quarters
|
|
1979
CNX Resources
CNX
$5.63B
| $64.4M | ﹤0.01% |
1,899,060
+190,650
| +11% | +$6.87M |
2013 Q2
52 quarters
|
|
1980
Kornit Digital
KRNT
$780M
| $64.4M | ﹤0.01% |
3,965,156
-37,011
| -0.9% | -$585K |
2017 Q1
37 quarters
|
|
1981
DELISTED
Janus Henderson
JHG
| $64.3M | ﹤0.01% |
1,238,193
-377,471
| -23% | -$19.5M |
2017 Q2
36 quarters
|
|
1982
OR Royalties Inc
OR
$6.37B
| $64.3M | ﹤0.01% |
2,033,058
+135,531
| +7% | +$5M |
2016 Q3
39 quarters
|
|
1983
Western Asset Inflation-Linked Opportunities & Income Fund
WIW
$486M
| $64.1M | ﹤0.01% |
7,634,301
+425,634
| +6% | +$3.61M |
2013 Q2
52 quarters
|
|
1984
Zillow
Z
$6.92B
| $64.1M | ﹤0.01% |
2,032,460
-540,835
| -21% | -$20.8M |
2015 Q3
43 quarters
|
|
1985
Goldman Sachs Access US Aggregate Bond ETF
GCOR
$811M
| $64M | ﹤0.01% |
1,554,686
+322,888
| +26% | +$13.3M |
2021 Q1
21 quarters
|
|
1986
Amrize Ltd
AMRZ
$21.9B
| $64M | ﹤0.01% |
1,200,250
+219,144
| +22% | +$11.9M |
2025 Q2
4 quarters
|
|
1987
VanEck High Yield Muni ETF
HYD
$4.52B
| $63.8M | ﹤0.01% |
1,238,896
-117,582
| -9% | -$6.01M |
2013 Q2
52 quarters
|
|
1988
US Global Jets ETF
JETS
$828M
| $63.8M | ﹤0.01% |
1,920,127
-2,159,111
| -53% | -$59.7M |
2016 Q2
40 quarters
|
|
1989
BlackRock Corporate High Yield Fund
HYT
$1.53B
| $63.7M | ﹤0.01% |
7,446,501
+828,449
| +13% | +$7.11M |
2013 Q2
52 quarters
|
|
1990
JPMorgan Municipal ETF
JMUB
$8.85B
| $63.7M | ﹤0.01% |
1,257,661
+92,404
| +8% | +$4.65M |
2024 Q4
6 quarters
|
|
1991
Associated Banc-Corp
ASB
$5.67B
| $63.7M | ﹤0.01% |
2,069,926
+651,079
| +46% | +$18.4M |
2013 Q2
52 quarters
|
|
1992
State Street SPDR S&P 400 Mid Cap Value ETF
MDYV
$2.77B
| $63.7M | ﹤0.01% |
671,315
-54,789
| -8% | -$4.99M |
2013 Q2
52 quarters
|
|
1993
Fluence Energy
FLNC
$886M
| $63.6M | ﹤0.01% |
3,201,307
+1,070,030
| +50% | +$19.9M |
2021 Q4
18 quarters
|
|
1994
CCC Intelligent Solutions
CCC
$4.53B
| $63.6M | ﹤0.01% |
12,328,314
-4,422,083
| -26% | -$21.9M |
2021 Q1
21 quarters
|
|
1995
Ryan Specialty Holdings
RYAN
$5.2B
| $63.5M | ﹤0.01% |
1,682,829
-596,030
| -26% | -$20.2M |
2021 Q3
19 quarters
|
|
1996
Thor Industries
THO
$3.67B
| $63.5M | ﹤0.01% |
845,259
+164,807
| +24% | +$12.7M |
2013 Q2
52 quarters
|
|
1997
Bath & Body Works
BBWI
$4.36B
| $63.4M | ﹤0.01% |
2,742,890
+195,770
| +8% | +$3.75M |
2013 Q2
52 quarters
|
|
1998
Ligand Pharmaceuticals
LGND
$6.36B
| $63.4M | ﹤0.01% |
200,699
+33,470
| +20% | +$7.89M |
2013 Q2
52 quarters
|
|
1999
Pacer US Large Cap Cash Cows Growth Leaders ETF
COWG
$2.4B
| $63.4M | ﹤0.01% |
1,580,176
+110,207
| +7% | +$4.1M |
2024 Q4
6 quarters
|
|
2000
Moelis & Co
MC
$4.32B
| $63.3M | ﹤0.01% |
968,210
+19,216
| +2% | +$1.26M |
2014 Q2
48 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 302 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 302 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.